Short Walks to Break Up Sitting for Type 2 Diabetes
Trial Summary
What is the purpose of this trial?
Type 2 diabetes (T2D) confers a high risk of cardiovascular disease (CVD), particularly among older adults who tend to be physically inactive. Prolonged sedentary behavior (SB) has been shown to negatively influence markers of cardiovascular risk (e.g., blood glucose, blood pressure), even among individuals who are physically active. Most studies that have examined the effects of breaking up SB have focused on young healthy males and prioritized glycemic outcomes. Additionally, sex differences in these outcomes have not been adequately examined. The present study will address these gaps. This 3-arm crossover randomized controlled trial will compare the effects of 3 SB conditions on markers of vascular function. The 3 conditions are: 1) 4 hours of prolonged SB, 2) 4 hours of SB broken up by 5 minutes of self-paced walking every hour, and 3) 4 hours of SB with one 20-minute bout of self-paced walking. In addition to examining the overall effects of each condition, sex differences in physiological responses will be evaluated.
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment of breaking up sitting time with short walks for people with type 2 diabetes?
Is breaking up sitting time with short walks safe for humans?
How does the treatment of breaking up sitting time differ from other treatments for type 2 diabetes?
Research Team
Mary O Whipple, PhD, RN, PHN
Principal Investigator
University of Minnesota
Eligibility Criteria
This trial is for people over 60 with Type 2 diabetes who are mostly inactive, sitting for more than 6 hours a day. It's not for those on dialysis, with a history of DVT, unstable conditions, recent hormone therapy changes, meeting exercise guidelines, physical disabilities affecting movement, Type 1 diabetes or uncontrolled high blood pressure.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 3 different sedentary behavior conditions to assess vascular function
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- prolonged SB (Behavioural Intervention)
- SB broken 1 (Behavioural Intervention)
- SB broken 2 (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
Shashank Priya
University of Minnesota
Chief Executive Officer since 2023
PhD in Materials Engineering from Penn State
Charles Semba
University of Minnesota
Chief Medical Officer since 2021
MD from the University of Minnesota Medical School